author-photo

Eleanor Mc Fadden

Shire plc

4

Papers

28

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER2-negative early breast cancer.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Management of Data in Clinical Trials

2015
- Eleanor Mc Fadden
Show All
- Source
- Cite
- Save
Citations (0)
OlympiA: A randomized phase III trial of olaparib as adjuvant therapy in patients with high-risk HER2-negative breast cancer (BC) and a germline BRCA1/2 mutation (gBRCAm).

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (22)
Management of Data in Clinical Trials

2015
- Eleanor Mc Fadden
Show All
- Source
- Cite
- Save
Citations (0)